OCHRATOXIN A
- CAS No.
- 303-47-9
- Chemical Name:
- OCHRATOXIN A
- Synonyms
- Ochratoxin A(OTA);Phe-OTA;n-(((3r)-5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl;(-)-n-((5-chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyla;l-phenylalanine,n-((5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1h-2-benzopy;(-)-l;lanine;IgG &NCTC-929;NCTC 929
- CBNumber:
- CB5325836
- Molecular Formula:
- C20H18ClNO6
- Molecular Weight:
- 403.81
- MDL Number:
- MFCD00078079
- MOL File:
- 303-47-9.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Melting point | 169°C |
|---|---|
| Boiling point | 632.4±55.0 °C(Predicted) |
| alpha | D -118° (c = 1.1 in CHCl3) |
| Density | 1.2459 (rough estimate) |
| refractive index | 1.6000 (estimate) |
| Flash point | 2 °C |
| storage temp. | 2-8°C |
| solubility | ethanol: soluble |
| form | powder |
| pka | 3.29±0.10(Predicted) |
| color | White to off-white |
| biological source | Aspergillus ochraceus |
| Merck | 13,6772 |
| BRN | 8169012 |
| Major Application |
cleaning products cosmetics food and beverages personal care |
| InChI | 1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1 |
| InChIKey | RWQKHEORZBHNRI-BMIGLBTASA-N |
| SMILES | C[C@@H]1Cc2c(Cl)cc(c(O)c2C(=O)O1)C(=O)N[C@@H](Cc3ccccc3)C(O)=O |
| Toxicology and Carcinogenesis | Toxicology and Carcinogenesis Studies of Ochratoxin A (CASRN 303-47-9) in F344/N Rats (Gavage Studies) |
| NCI Dictionary of Cancer Terms | L |
| FDA UNII | 1779SX6LUY |
| Proposition 65 List | Ochratoxin A |
| IARC | 2B (Vol. Sup 7, 56) 1993 |
| EPA Substance Registry System | Ochratoxin A (303-47-9) |
| UNSPSC Code | 85151701 |
| NACRES | NA.77 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS06,GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H300+H310+H330-H350-H360 | |||||||||
| Precautionary statements | P202-P260-P264-P280-P302+P352+P310-P304+P340+P310 | |||||||||
| PPE | Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter | |||||||||
| Hazard Codes | T+,T,Xn,F | |||||||||
| Risk Statements | 45-46-61-26/27/28-36-20/21/22-11-40-28-39/23/24/25-23/24/25-65-48/23/24/25-36/38 | |||||||||
| Safety Statements | 53-22-36/37/39-45-36-26-16-36/37-28-62 | |||||||||
| RIDADR | UN 3462 6.1/PG 2 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | AY4375000 | |||||||||
| F | 10 | |||||||||
| HazardClass | 6.1(a) | |||||||||
| PackingGroup | I | |||||||||
| HS Code | 29322985 | |||||||||
| Storage Class | 3 - Flammable liquids | |||||||||
| Hazard Classifications | Acute Tox. 4 Dermal Acute Tox. 4 Inhalation Acute Tox. 4 Oral Eye Irrit. 2 Flam. Liq. 2 |
|||||||||
| Hazardous Substances Data | 303-47-9(Hazardous Substances Data) | |||||||||
| Toxicity | LD50 orally in rats: 20-22 mg/kg (Purchase, Theron) | |||||||||
| NFPA 704 |
|
OCHRATOXIN A price More Price(38)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | O3007 | Ochratoxin A−BSA conjugate from Aspergillus ochraceus | 303-47-9 | 5MG | $1280 | 2026-04-30 | Buy |
| Sigma-Aldrich | O1877 | Ochratoxin A from Petromyces albertensis, ≥98% (HPLC) | 303-47-9 | 25mg | $2130 | 2026-04-30 | Buy |
| Sigma-Aldrich | CRM46912 | Ochratoxin A solution certified reference material, 50?μg/mL in benzene: acetic acid (99:1), ampule of 1?mL | 303-47-9 | 1mL | $149 | 2026-04-30 | Buy |
| Sigma-Aldrich | 34037 | Ochratoxin A solution 10?μg/mL in acetonitrile, analytical standard | 303-47-9 | 2ml | $530 | 2026-04-30 | Buy |
| Cayman Chemical | 11439 | Ochratoxin A ≥98% | 303-47-9 | 1mg | $72 | 2026-04-30 | Buy |
OCHRATOXIN A Chemical Properties, Uses, Production
Chemical Properties
white to off-white crystalline powder
Chemical Properties
White crystalline solid or powder.
Uses
A nephrotoxic mycotoxin inhibitor of phenylalanyl-tRNA synthetases.
Uses
Ochratoxins are toxic metabolites from Aspergillus orchraceus.
Uses
Ochratoxin A is a chlorinated benzopyran coupled to phenylalanine, produced by several Aspergillus and Penicillium sp. associated with food spoilage. Ochratoxins are widely distributed in the environment and are known to be nephrotoxic, teratogenic and possibly carcinogenic. Ochratoxin A may act by inducing DNA strand breaks, sister chromatid exchanges, DNA adduct formation, or reactive oxygen but the mechanism of action as a toxin is not yet resolved. At the molecular level, ochratoxin A specifically inhibits NK cell activity, increases growth of transplantable tumour cells in mice, increases apoptosis, activates c-Jun N terminal kinase in human kidney epithelial cells, and blocks metaphase/anaphase transition. It also inhibits plasminogen activator inhibitor-2 production by human blood mononuclear cells.
Definition
ChEBI: A phenylalanine derivative resulting from the formal condensation of the amino group of L-phenylalanine with the carboxy group of (3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carb xylic acid. It is among the most widely occurring food-contaminating mycotoxins, produced by Aspergillus ochraceus, Aspergillus carbonarius and Penicillium verrucosum.
General Description
White crystalline powder.
Air & Water Reactions
Insoluble in water.
Reactivity Profile
OCHRATOXIN A is incompatible with strong oxidizing agents, strong acids and strong bases. . OCHRATOXIN A is a carboxylic acid derivative. Carboxylic acids donate hydrogen ions if a base is present to accept them. They react in this way with all bases, both organic (for example, the amines) and inorganic. Their reactions with bases, called "neutralizations", are accompanied by the evolution of substantial amounts of heat. Neutralization between an acid and a base produces water plus a salt.
Hazard
Hepatotoxic, nephrotoxic, extremely toxic; possible carcinogen.
Fire Hazard
Flash point data for OCHRATOXIN A are not available; however, OCHRATOXIN A is probably combustible.
Biological Activity
Mycotoxin that increases activity of the endoplasmic reticulum ATP-dependent calcium pump. Induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. Stimulates lipid peroxidation.
Safety Profile
Confirmed carcinogen with carcinogenic and neoplastigenic data. Poison by ingestion, intraperitoneal, intravenous, and subcutaneous routes. Experimental teratogenic and reproductive effects. Mutation data reported. When heated to decomposition it emits very toxic fumes of Cland NOx.
Potential Exposure
Ochratoxin A, a carboxylic acid derivative and a naturally occurring toxic mold (strain of Aspergillus ochraceus), occasionally in storage grains such as wheat and on field crops such as corn and oilseed (i.e., cottonseed), in ancient tombs, and decayed vegetation. Used as a laboratory chemical for research. Not currently produced in the United States.
Carcinogenicity
Ochratoxin A is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in experimental animals.
Shipping
UN2811 Toxic solids, organic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials, Technical Name Required. UN3462 Toxins, extracted from living sources, solid, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials, Technical Name Required.
Incompatibilities
Ochratoxin A is Incompatible with oxidizers (chlorates, nitrates, peroxides, permanganates, perchlorates, chlorine, bromine, fluorine, etc.); contact may cause fire. Keep away from alkaline materials, strong bases, strong acids, oxoacids, and epoxides. Compounds of the carboxyl group R.COOH Compounds of the carboxyl group react with all bases, both inorganic and organic (i.e.,amines) releasing substantial heat, water, and a salt that may be harmful. Incompatible with arsenic compounds (releases hydrogen cyanide gas), diazo compounds, dithiocarbamates, isocyanates, mercaptans, nitrides, and sulfides (releasing heat, toxic, and possibly flammable gases), thiosulfates and dithionites (releasing hydrogen sulfate and oxides of sulfur).
Waste Disposal
Consult with environmental regulatory agencies for guidance on acceptable disposal practices. Generators of waste containing this contaminant (≥100 kg/mo) must conform with EPA regulations governing storage, transportation, treatment, and waste disposal. Under 40 CFR 261.5 small quantity generators of this waste may qualify for partial exclusion from hazardous waste regulations.
OCHRATOXIN A Preparation Products And Raw materials
303-47-9 (OCHRATOXIN A) Related Search:
1of4
